Singapore markets closed
Straits Times Index
3,265.95 +1.42 (+0.04%) S&P 500
5,187.67 -0.03 (-0.00%) Dow
39,056.39 +172.13 (+0.44%) Nasdaq
16,302.76 -29.80 (-0.18%) Bitcoin USD
60,990.66 -1,391.33 (-2.23%) CMC Crypto 200
1,320.05 +19.96 (+1.53%)
Zimmer Biomet Holdings, Inc. (ZBH)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 24.86B |
| Enterprise value | 30.43B |
| Trailing P/E | 26.21 |
| Forward P/E | 15.02 |
| PEG ratio (5-yr expected) | 1.82 |
| Price/sales (ttm) | 3.38 |
| Price/book (mrq) | 1.97 |
| Enterprise value/revenue | 4.08 |
| Enterprise value/EBITDA | 14.10 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.03 |
| 52-week change 3 | -11.59% |
| S&P500 52-week change 3 | 25.59% |
| 52-week high 3 | 147.50 |
| 52-week low 3 | 102.00 |
| 50-day moving average 3 | 124.85 |
| 200-day moving average 3 | 119.87 |
Share statistics
| Avg vol (3-month) 3 | 1.33M |
| Avg vol (10-day) 3 | 1.62M |
| Shares outstanding 5 | 205.73M |
| Implied shares outstanding 6 | 205.73M |
| Float 8 | 205.21M |
| % held by insiders 1 | 0.13% |
| % held by institutions 1 | 90.90% |
| Shares short (15 Apr 2024) 4 | 4.25M |
| Short ratio (15 Apr 2024) 4 | 3.61 |
| Short % of float (15 Apr 2024) 4 | 2.34% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.07% |
| Shares short (prior month 15 Mar 2024) 4 | 4.59M |
Dividends & splits
| Forward annual dividend rate 4 | 0.96 |
| Forward annual dividend yield 4 | 0.79% |
| Trailing annual dividend rate 3 | 0.96 |
| Trailing annual dividend yield 3 | 0.79% |
| 5-year average dividend yield 4 | 0.74 |
| Payout ratio 4 | 20.82% |
| Dividend date 3 | 30 Apr 2024 |
| Ex-dividend date 4 | 27 Mar 2024 |
| Last split factor 2 | 103:100 |
| Last split date 3 | 01 Mar 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 12.93% |
| Operating margin (ttm) | 20.78% |
Management effectiveness
| Return on assets (ttm) | 4.43% |
| Return on equity (ttm) | 7.80% |
Income statement
| Revenue (ttm) | 7.45B |
| Revenue per share (ttm) | 35.89 |
| Quarterly revenue growth (yoy) | 3.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 2.47B |
| Net income avi to common (ttm) | 963.9M |
| Diluted EPS (ttm) | 4.60 |
| Quarterly earnings growth (yoy) | -25.90% |
Balance sheet
| Total cash (mrq) | 393M |
| Total cash per share (mrq) | 1.91 |
| Total debt (mrq) | 6.01B |
| Total debt/equity (mrq) | 47.68% |
| Current ratio (mrq) | 1.66 |
| Book value per share (mrq) | 61.24 |
Cash flow statement
| Operating cash flow (ttm) | 1.5B |
| Levered free cash flow (ttm) | 1.07B |
© 2024 Yahoo. All rights reserved.